机构:[1]Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[3]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院
第一作者机构:[1]Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.[2]Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
推荐引用方式(GB/T 7714):
Hu Mingming,Liao XuLiang,Tao Yi,et al.Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma[J].Frontiers In Immunology.2023,14:1352909.doi:10.3389/fimmu.2023.1352909.
APA:
Hu Mingming,Liao XuLiang,Tao Yi&Chen Yaohui.(2023).Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.Frontiers In Immunology,14,
MLA:
Hu Mingming,et al."Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma".Frontiers In Immunology 14.(2023):1352909